cro.directory
← Compare landing

MMS Holdings vs Novotech

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/mmsholdings/novotech-cro

CategoryMMS HoldingsNovotech
Listed sitecrocro
SummaryData-focused CRO providing full-spectrum biometrics, regulatory submissions, safety & risk management, and therapeutic expertise across oncology, CNS, rare diseases, and psychedelics. Named Best Specialist CRO at the Scrip Awards with zero refusals to file on 50+ marketing applications in five years.Global full-service CRO specializing in early-phase and oncology trials across 50+ countries, with expertise in cardiovascular, cell and gene therapy, and radiopharmaceutical development.
Services
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Clinical Operations
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Oncology Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Immunology & Inflammation Services
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Central Laboratory Services
  • Bioanalysis
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Vaccine
  • Radiopharmaceutical
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Radiopharmaceutical
Indications
  • Oncology
  • Neurology
  • Rare Disease
  • Psychiatry
  • Infectious Disease
  • Oncology
  • Immunology
  • Cardiovascular
Locations
  • Global headquarters
  • Headquarters, Sydney, New South Wales, Australia
  • Regional Office, Singapore, Singapore
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.